B. Rutz

发表

Smooth muscle contraction and growth of stromal cells in the human prostate are both inhibited by the Src family kinase inhibitors, AZM475271 and PP2

C. Stief, Chunxiao Liu, C. Gratzke, 2016, British journal of pharmacology.

Inhibition of human prostate smooth muscle contraction by the LIM kinase inhibitors, SR7826 and LIMKi3

C. Stief, C. Gratzke, A. Herlemann, 2018, British journal of pharmacology.

Inhibition of agonist‐induced smooth muscle contraction by picotamide in the male human lower urinary tract outflow region

C. Stief, M. Schott, C. Gratzke, 2017, European journal of pharmacology.

Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gαq/11 Inhibitor, YM-254890

C. Stief, A. Tamalunas, M. Hennenberg, 2022, Frontiers in Physiology.

Rac1 silencing, NSC23766 and EHT1864 reduce growth and actin organization of bladder smooth muscle cells.

C. Stief, M. Hennenberg, Yiming Wang, 2020, Life sciences.

Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864

C. Stief, C. Gratzke, R. Waidelich, 2015, British journal of pharmacology.

Non‐Adrenergic, Tamsulosin‐Insensitive Smooth Muscle Contraction is Sufficient to Replace α1‐Adrenergic Tension in the Human Prostate

C. Stief, C. Gratzke, A. Herlemann, 2017, The Prostate.

Lenalidomide and pomalidomide inhibit growth of prostate stromal cells and human prostate smooth muscle contraction.

C. Stief, C. Gratzke, A. Tamalunas, 2021, Life sciences.

Inhibition of human prostate stromal cell growth and smooth muscle contraction by thalidomide: A novel remedy in LUTS?

C. Stief, C. Gratzke, A. Tamalunas, 2021, The Prostate.

The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor

C. Stief, R. Waidelich, A. Tamalunas, 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.

Inhibition of smooth muscle contraction and ARF6 activity by the inhibitor for cytohesin GEFs, secinH3, in the human prostate.

C. Stief, M. Schott, C. Gratzke, 2018, American journal of physiology. Renal physiology.

Expression and alpha1-adrenoceptor regulation of caldesmon in human prostate smooth muscle.

C. Stief, C. Gratzke, A. Roosen, 2012, Urology.

Inhibition of smooth muscle contraction and ARF 6 activity 1 by the inhibitor for cytohesin GEFs , secinH 3 in the human 2 prostate 3 4

C. Stief, M. Schott, C. Gratzke, 2022 .

Inhibition of neurogenic and thromboxane A2‐induced human prostate smooth muscle contraction by the integrin α2β1 inhibitor BTT‐3033 and the integrin‐linked kinase inhibitor Cpd22

C. Stief, C. Gratzke, A. Spek, 2020, The Prostate.

Purinergic smooth muscle contractions in the human prostate: estimation of relevance and characterization of different agonists

C. Stief, A. Spek, R. Waidelich, 2021, Naunyn-Schmiedeberg's Archives of Pharmacology.

ADP Ribosylation Factor 6 Promotes Contraction and Proliferation, Suppresses Apoptosis and Is Specifically Inhibited by NAV2729 in Prostate Stromal Cells

C. Stief, O. Keppler, M. Hennenberg, 2021, Molecular Pharmacology.

Noradrenaline induces binding of Clathrin light chain A to α1‐adrenoceptors in the human prostate

C. Stief, C. Gratzke, R. Waidelich, 2013, The Prostate.

Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α1-blockers.

M. Erlander, C. Stief, R. Waidelich, 2020, European journal of pharmacology.

Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases

C. Stief, C. Gratzke, A. Herlemann, 2018, Front. Physiol..

Permixon®, hexane-extracted Serenoa repens, inhibits human prostate and bladder smooth muscle contraction and exerts growth-related functions in human prostate stromal cells.

C. Stief, T. Kolben, Victor Vigodski, 2022, Life sciences.

Silodosin Inhibits Noradrenaline-Activated Transcription Factors Elk1 and SRF in Human Prostate Smooth Muscle

F. Montorsi, C. Stief, C. Gratzke, 2012, PloS one.

Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate.

C. Stief, C. Gratzke, K. Andersson, 2014, American journal of physiology. Renal physiology.

Cooperative effects of EGF, FGF, and TGF-β1 in prostate stromal cells are different from responses to single growth factors.

C. Stief, C. Gratzke, R. Waidelich, 2015, Life sciences.

The cAMP effector EPAC activates Elk1 transcription factor in prostate smooth muscle, and is a minor regulator of α1-adrenergic contraction

C. Stief, C. Gratzke, M. Hennenberg, 2013, Journal of Biomedical Science.

Inhibition of Adrenergic and Non‐Adrenergic Smooth Muscle Contraction in the Human Prostate by the Phosphodiesterase 10‐Selective Inhibitor TC‐E 5005

C. Stief, M. Schott, C. Gratzke, 2016, The Prostate.

Activation of protein kinase B/Akt by alpha1-adrenoceptors in the human prostate.

C. Stief, C. Gratzke, A. Roosen, 2012, Life sciences.

The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle.

C. Stief, C. Gratzke, Y. Hocaoglu, 2013, American journal of physiology. Renal physiology.

P21-Activated Kinase Inhibitors FRAX486 and IPA3: Inhibition of Prostate Stromal Cell Growth and Effects on Smooth Muscle Contraction in the Human Prostate

C. Stief, Chunxiao Liu, C. Gratzke, 2016, PloS one.

Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003

C. Stief, R. Waidelich, A. Tamalunas, 2023, Frontiers in Pharmacology.

Ghrelin Aggravates Prostate Enlargement in Rats with Testosterone-Induced Benign Prostatic Hyperplasia, Stromal Cell Proliferation, and Smooth Muscle Contraction in Human Prostate Tissues

C. Stief, Chunxiao Liu, C. Gratzke, 2019, Oxidative medicine and cellular longevity.

Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein‐coupled receptor kinase 2/3, CMPD101

Frank Strittmatter, Christian Gratzke, Christian G. Stief, 2018, European journal of pharmacology.

The STK16 inhibitor STK16-IN-1 inhibits non-adrenergic and non-neurogenic smooth muscle contractions in the human prostate and the human male detrusor

C. Stief, R. Waidelich, A. Tamalunas, 2019, Naunyn-Schmiedeberg's Archives of Pharmacology.

A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate

C. Stief, C. Gratzke, A. Herlemann, 2019, The Journal of Biological Chemistry.

369 Expression of monoacylglycerase (MAGL) in the human lower urinary tract: A new target for intervention into the endocannabinoid system?

C. Stief, C. Gratzke, M. Hennenberg, 2014 .

The cAMP effector EPAC activates Elk1 transcription factor in prostate smooth muscle, and is a minor regulator of α1-adrenergic contraction

C. Stief, C. Gratzke, M. Hennenberg, 2013, Journal of Biomedical Science.

Immunomodulatory imide drugs inhibit human detrusor smooth muscle contraction and growth of human detrusor smooth muscle cells, and exhibit vaso-regulatory functions.

A. Tamalunas, M. Hennenberg, B. Rutz, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The receptor antagonist picotamide inhibits adrenergic and thromboxane-induced contraction of hyperplastic human prostate smooth muscle.

C. Stief, C. Gratzke, Y. Hocaoglu, 2013, American journal of physiology. Renal physiology.